Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries

BMC Medical Research Methodology

Jean-Marie Robine¹  Wilma Nusselder³  Carol Jagger⁶  Tony Fouweather⁶  Emmanuelle Cambois²  Herman Van Oyen⁴  Nicolas Berger⁵ 

[1]École Pratique des Hautes Études, Montpellier, France

[2]French Institute for Demographic Studies (INED), Paris, France

[3]Department of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

[4]Public Health and Surveillance, Scientific Institute of Public Health, Rue Juliette Wytsmanstraat 14, 1050 Brussels, Belgium

[5]Faculty of Public Health & Policy, London School of Hygiene & Tropical Medicine, London, UK

[6]Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK

关键词: Measurement;    Functioning;    Disability;    Healthy life years;    Disability-free life expectancy;    Health expectancy;    Global activity limitation indicator;   

Others  :  1090151
DOI  :  10.1186/1471-2288-15-1

 received in 2013-12-05, accepted in 2014-12-23,  发布年份 2015

【 摘 要 】

Background

The Global Activity Limitation Indicator (GALI), the measure underlying the European indicator Healthy Life Years (HLY), is widely used to compare population health across countries. However, the comparability of the item has been questioned. This study aims to further validate the GALI in the adult European population.

Methods

Data from the European Health Interview Survey (EHIS), covering 14 European countries and 152,787 individuals, were used to explore how the GALI was associated with other measures of disability and whether the GALI was consistent or reflected different disability situations in different countries.

Results

When considering each country separately or all combined, we found that the GALI was significantly associated with measures of activities of daily living, instrumental activity of daily living, and functional limitations (P < 0.001 in all cases). Associations were largest for activity of daily living and lowest though still high for functional limitations. For each measure, the magnitude of the association was similar across most countries. Overall, however, the GALI differed significantly between countries in terms of how it reflected each of the three disability measures (P < 0.001 in all cases). We suspect cross-country differences in the results may be due to variations in: the implementation of the EHIS, the perception of functioning and limitations, and the understanding of the GALI question.

Conclusion

The study both confirms the relevance of this indicator to measure general activity limitations in the European population and the need for caution when comparing the level of the GALI from one country to another.

【 授权许可】

   
2015 Berger et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Jagger C, McKee M, Christensen K, Lagiewka K, Nusselder W, Van Oyen H, et al.: Mind the gap - reaching the European target of a 2-year increase in healthy life years in the next decade. Eur J Public Health 2013, 23:829-33.
• [2]Lagiewka K: European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020. Arch Public Health 2012, 70:23. BioMed Central Full Text
• [3]Oortwijn W, Mathijssen J, Lankhuizen M, Cave J: Evaluating the Uptake of the Healthy Life Years Indicator. Brussels: Rand-Europe; 2006:1-74.
• [4]Van Oyen H, Van der Heyden J, Perenboom R, Jagger C: Monitoring population disability: evaluation of a new Global Activity Limitation Indicator (GALI). Soz Praventivmed 2006, 51:153-61.
• [5]Tubeuf S, Jusot F, Devaux M, Sermet C: Social Heterogeneity in Self-reported Health Status and Measurement of Inequalities in Health. Paris: Irdes; 2008.
• [6]Cambois E, Robine JM, Mormiche P: Did the prevalence of disability in France really fall sharply in the 1990s? Popul (Engl edition) 2007, 62:313-37.
• [7]Jagger C, Gillies C, Cambois E, Van Oyen H, Nusselder W, Robine JM: The Global Activity Limitation Index measured function and disability similarly across European countries. J Clin Epidemiol 2010, 63:892-9.
• [8]Robine JM, Cambois E, Nusselder W, Jeune B, Van Oyen H, Jagger C: The joint action on healthy life years (JA: EHLEIS). Arch Public Health 2013, 71:2. BioMed Central Full Text
• [9]Gauci D: Synthesis Report on use of EHIS Quality Assessment Criteria. Malta: Department of Health Information and Research; 2011.
• [10]Tuomi-Nikalu A, Ahonen S, Koponen P: Comparison of EHIS Source Questions With National Survey Questions. Helsinki: National Institute for Health and Welfare; 2011.
• [11]Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, et al.: Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. Lancet 2008, 372:2124-31.
• [12]Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963, 185:914-9.
• [13]Verbrugge LM, Merrill SS, Liu X: Measuring disability with parsimony. Disabil Rehabil 1999, 21:295-306.
• [14]Lawton M, Brody E: Assessment of older people: Self-maintenance and Instrumental Activities of Daily Living. Gerontology 1969, 9:179-86.
• [15]Verbrugge LM, Jette AM: The disablement process. Soc Sci Med 1994, 38:1-14.
• [16]Robine JM, Jagger C, Egidi V, Gispert M, Nusselder W, Perenboom R, et al.: Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project. Eur J Public Health 2003, 13:6-14.
• [17]de Bruin A, Picavet HS, Nossikov A: Health Interview Surveys: Towards International Harmonization of Methods and Instruments. Copenhagen: World Health Organisation; 1996.
• [18]Cochran WG: The combination of estimates from different experiments. Biometrics 1954, 10:101-29.
• [19]Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-58.
• [20]Deeg DJ, Verbrugge LM, Jagger C: Disability measurement. In Determining Health Expectancies. Edited by Robine JM, Jagger C, Mathers CD, Crimmins EM. Chichester, UK: Wiley Online Library; 2003:203-19.
• [21]Bowling A: Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 2005, 27:281-91.
• [22]King G, Murray C, Salomon J, Tandon A: Enhancing the validity and cross-cultural comparability of measurement in survey research. Am Polit Sci Rev 2003, 97:567-84.
• [23]Angelini V, Cavapozzi D, Paccagnella O: Cross-country differentials in work disability reporting among older Europeans. Soc Indic Res 2012, 105:211-26.
• [24]Jylhä M: What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Soc Sci Med 2009, 69:307-16.
• [25]Verma V: Issues in Data Quality and Comparability in EU-SILC. 2006. http://www.stat.fi/eusilc/verma_5-1.pdf webcite
• [26]The JA: EHLEIS Team. [ http://www.eurohex.eu/index.php?option=aboutehemu#team webcite]